SCHEMBL2016247

SCHEMBL2016247

NCc1cccc(CCC(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.61
PTPRB P23467 1/20 0.57
CDC25A P30304 1/20 0.57
CDC25B P30305 1/20 0.57
PTEN P60484 1/20 0.57
PTPMT1 Q8WUK0 1/20 0.57
FFAR1 O14842 6/20 0.57
SIRT1 Q96EB6 1/20 0.49
ENPP2 Q13822 1/20 0.48
LOXL2 Q9Y4K0 2/20 0.48
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
TBXA2R P21731 1/20 0.48
HDAC3 O15379 1/20 0.47
MAPK1 P28482 1/20 0.47
ADRA1A P35348 1/20 0.47
HDAC4 P56524 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HDAC1 Q13547 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273986 1.00 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
Phenyl Propionic Acid SCHEMBL6660445 0.96 KEAP1 (0.68) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL70271 0.90 KEAP1 (0.74) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL1666941 0.89 SMN1; SMN2 (0.63) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL5264276 0.89 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
Hydrochloric Acid SCHEMBL10982620 0.88 KEAP1 (0.71) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL19313223 0.87 MAPT (0.62) KEAP1HDAC3MAPK1ADRA1AHDAC4
Hydrochloric Acid SCHEMBL27491907 0.87 SMN1; SMN2 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
Adipic Acid SCHEMBL272108 0.86 MAPT (0.55) KEAP1ENPP2LOXL2HDAC3MAPK1
Adipic Acid SCHEMBL5694409 0.85 MAPT (0.53) KEAP1FFAR1ENPP2LOXL2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101371199-B Photoresist stripper composition for semiconductor manufacturing TECHNO SEMICHEM CO LTD 2012-05-30 CN claimed
CN-101371199-A Photoresist stripper composition for semiconductor manufacturing TECHNO SEMICHEM CO LTD (KR) 2009-02-18 CN claimed
US-11945806-B2 Stabilization of amyloidogenic immunoglobulin light chains THE SCRIPPS RESEARCH INSTITUTE 2024-04-02 US disclosed
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 US disclosed
CN-114127050-A Benzopyran and imidazole derivatives useful for stabilizing amyloidogenic immunoglobulin light chains 斯克利普斯研究所 2022-03-01 CN disclosed
EP-3946604-A1 BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS The Scripps Research Institute (US) 2022-02-09 EP disclosed
WO-2020205683-A1 BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE (US) 2020-10-08 WO disclosed
CN-109843866-A YAP1 inhibitors targeting YAP1 interaction with OCT4 H·李·莫菲特癌症中心研究有限公司 2019-06-04 CN disclosed
CN-105481806-B The synthetic method of the 5-membered ring compounds containing sulfuryl and application 华南理工大学 2018-09-14 CN disclosed
CN-105777688-B A kind of synthetic method of γ pyranone compounds 中国药科大学 2017-12-15 CN disclosed
EP-2630196-B1 CYANINE DYES AND THEIR CONJUGATES LI COR INC (US) 2017-09-06 EP disclosed
CN-1870999-A Alkynes I ASTRAZENECA AB (SE) 2006-11-29 CN disclosed
CN-1826325-A 4,5-dihydro-imidazole as P2X7 ion channel blockers AVENTIS PHARMA INC (US) 2006-08-30 CN disclosed
EP-1401434-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) ELI LILLY AND COMPANY (US) 2004-03-31 EP disclosed
WO-2002100403-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) ELI LILLY AND COMPANY (US) 2002-12-19 WO disclosed
EP-0716661-B1 PSEUDO- AND NON-PEPTIDE BRADYKININ RECEPTOR ANTAGONISTS SCIOS INC (US) 2000-04-05 EP disclosed
US-5541286-A Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids SCIOS NOVA INC. (US) 1996-07-30 US disclosed
EP-0716661-A1 PSEUDO- AND NON-PEPTIDE BRADYKININ RECEPTOR ANTAGONISTS SCIOS NOVA INC. (US) 1996-06-19 EP disclosed
US-5444048-A Antiinflammatory agents, analgesics SCIOS NOVA, INC. (US) 1995-08-22 US disclosed
WO-1995007294-A1 PSEUDO- AND NON-PEPTIDE BRADYKININ RECEPTOR ANTAGONISTS SCIOS NOVA INC. (US) 1995-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 KEAP1 1409/4885PTPRB 2321/4885CDC25A 2324/4885
US-11945806-B2 Stabilization of amyloidogenic immunoglobulin light chains TTR, MAP1LC3B, SAAL1 KEAP1 1409/4885PTPRB 2321/4885CDC25A 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.